These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15124272)

  • 1. Ophthalmologic monitoring for antimalarial toxicity.
    Sfikakis PP; Mavrikakis M
    J Rheumatol; 2004 May; 31(5):1011-2; author reply 1012. PubMed ID: 15124272
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transitory retinopathy caused by prolonged treatment with hydroxychloroquine sulfate].
    Chiari JJ; Freyberg RH
    Arch Med Panamenos; 1965 Apr; 14(1):23-32. PubMed ID: 5839434
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to ophthalmologic monitoring for antimalarial toxicity in a lupus cohort.
    Bernatsky S; Pineau C; Joseph L; Clarke A
    J Rheumatol; 2003 Aug; 30(8):1756-60. PubMed ID: 12913931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.
    Kobak S; Deveci H
    Int J Rheum Dis; 2010 Aug; 13(3):e11-5. PubMed ID: 20704603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Wolfe F; Marmor MF
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 10. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
    Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
    J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimalarials in the treatment of rheumatoid arthritis.
    Zvaifler NJ
    Mod Treat; 1971 Nov; 8(4):769-77. PubMed ID: 4258497
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
    Cabral RTS; Klumb EM; Couto MINN; Carneiro S
    Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of antimalarial drugs in rheumatoid arthritis.
    Rynes RI
    Agents Actions Suppl; 1993; 44():151-7. PubMed ID: 8372725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine-induced retinopathy: a dermatologic perspective.
    Tripp JM; Maibach HI
    Am J Clin Dermatol; 2006; 7(3):171-5. PubMed ID: 16734504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular toxicity of hydroxychloroquine.
    Tehrani R; Ostrowski RA; Hariman R; Jay WM
    Semin Ophthalmol; 2008; 23(3):201-9. PubMed ID: 18432546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.